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This paper is written by four authors from four European
Registries that serve the treatment of endstage renal failure
(ESRF). Each of these Registries is introduced by a short
historical note. We enjoy informal professional links and are
developing patient linkage to facilitate checking and inter-
change of data.
The purpose of this paper is to give a "glimpse behind the
scenes" into the methodologies evolving within and between
the Registries. Some developments have been necessitated by
the particular problems of maintaining patient files which are as
accurate and comprehensive as possible; others are required to
optimize research into the large data bases which have now
been accumulated. We report methods under development by
our four Registries for assessing the accuracy of the large
patient files and using these data bases for effective research
and to improve our service to the contributing centers.
Historical development offour European registries
Our four European Registries have been in operation for
more than 10 years. Three of these Registries, Eurotransplant,
Scandiatransplant, and the United Kingdom Transplant Service
exist primarily to promote the interchange of donor organs. The
patient Registry of the European Dialysis and Transplant As so-
ciation (EDTA) arose out of the need to record statistical data in
the treatment of ESRF and as a collaborative research organiza-
tion sponsored by its parent scientific association (EDTA).
The EDTA Registry collected returns from centers from the
start of treatment of ESRF in Europe. In August 1965, replies
were received from 43 centers who had treated 271 patients of
whom 160 were surviving. At that time it was thought appropri-
ate to ask whether the centers believed that regular dialysis
treatment was a satisfactory alternative to death from endstage
kidney disease and 95% answered "yes" [1]. From 1965 to 1970
a manual analysis of questionnaires was carried out in Amster-
dam for dialysis patients and in Leeds for transplanted patients.
In 1970, Parsons et al [2] introduced computerized techniques
to calculate survival and a combined Registry was established
with commercial (IBM) computerized facilities in Munich of
approximately 3,000 patients who were alive on dialysis and
transplantation. In 1976 this Registry, now with almost 30,000
live patients, moved to London, utilizing computing facilities at
Bristol. Independent computing facilities have now been estab-
lished at St. Thomas' Hospital, London, United Kingdom,
using a dedicated minicomputer. The computer files now hold
over 80,000 live patient records from 32 different countries [3].
Statistical reports from the Registry are presented at the
annual Congresses of EDTA and other reports, and research
papers have been presented in a variety of journals. The
Registry is funded by grants from Governments and National
Societies, industry and from the Association itself.
Eurotranspiant (ET) was founded in 1967 following a sugges-
tion by Van Rood [4] that large scale international co-operation
could improve a patient's chances of obtaining a well-matched
donor organ. A total of 118 centers participate in the organiza-
tion, including 37 typing centers and 39 transplantation centers
in four countries (Austria, Belgium, Germany, and the Nether-
lands) with a population of approximately 100 million.
Under its auspices, 8,912 transplantations were performed
between 1968 and 1981. There were 3,169 patients on its waiting
list for transplantation at the end of 1981. In that same year, 952
donors resulted in 1,343 transplantations, a rate of effectiveness
of 1.41. That value is continuously improving over the years. It
was only 0.58 in 1970 and 1.07 in 1975 [5].
Standardized sets of typing sera are distributed free to the
typing centers and Quality Control Workshops are carried out
regularly to maintain the reliability of the typings which form
the core of the matching program.
Scandiatransplant (ST) was begun in 1969 with the purpose of
improving HLA matching in cadaver kidney transplants. It is
funded by National Health Services coordinated by the Nordic
Council of Ministers and covers 12 transplant centers in Fin-
land, Norway, Sweden, Denmark, and Iceland—a total popula-
tion of about 25 million. The total number of transplant opera-
tions recorded to the close of 1982 was 6,103, and the number of
transplants performed during 1982 was 496. A scientific confer-
ence is held every second year.
The United Kingdom Transplant Service (UKTS) came into
being in February, 1972. The purpose in establishing this
organization was to optimize the use of available donor kidneys
by matching programs and arranging transportation. It is cen-
trally funded by the Department of Health and Social Security.
During the first 10 years, 7,039 cadaver transplants were
registered for the total population of the United Kingdom and
Ireland of 59.2 million. The number of patients on the waiting
list December 31, 1982, was 2,494, and 1,098 cadaver kidney
transplants were performed in 1982. The UKTS publishes an
Annual Report containing "business" statistics and scientific
analyses together with an assessment of the contemporary
scene in transplantation in the United Kingdom. The report and
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activities of UKTS are discussed at an annual meeting attended
by representatives of the 33 renal transplant units in the United
Kingdom who are the "users" of the service.
The patients on whom UKTS collects data are a subset of
those on whom the EDTA Registry, with its wider interest in
patients receiving dialysis as well as transplantation, collects
information. Since 1975 a "data interface" has existed between
the EDTA Registry and the UKTS computer files [6]. This
process is simple in its concept and has been extended to serve
Eurotransplant, Scandiatransplant, and France Transplant. The
EDTA record of patients, who are also transplant recipients
registered with the transplant organizations, contains the trans-
plant registry identification, code, and number. In the case of
UKTS, a reciprocal situation also exists in that the patient's
EDTA identification forms part of the UKTS patient record.
The linkage establishes a two-way data exchange leading to a
substantial rationalization of data collection to avoid unneces-
sary duplication.
The process of cross-referencing EDTA records with those of
the transplant exchange organizations is not particularly prob-
lematical in its implementation. It has, however, benefited both
sides in the way it exhibits anomalies in the data. EDTA data
are collected annually on a calendar year basis, while the
transplant organizations tend to collect much of their data
"hot," that is, at the time of transplantation, and the rest at
defined intervals after grafting.
The "cold" EDTA data have a higher incidence of anomalies
in terms of transplantation dates and unreported grafts which
can be corrected via the transplant organizations. A potential
difficulty exists when data are provided from the EDTA data
base to those of the transplant organizations. EDTA data is
organized as patient records whereas the transplant organiza-
tions arrange their file on the basis of transplant records. No
real problem arises in the accurate transmission of data relating
to a particular graft because graft date comparisons are readily
made for cross-checking.
Methods for recording follow-up of patients
Handling of patient transfers (EDTA). Patient movement
between centers is a major problem for the EDTA Registry.
Responsibility for the clinical care of patients is often trans-
ferred from one unit to another. From the Registry's point of
view, it is important to maintain the continuity of each individ-
ual record and to avoid the creation of duplicate records.
An important step was the introduction, in 1976, of a system
giving each patient on the register a unique number which is
now allocated within the computer. Until 1978, if a patient
moved, then his entire record was taken to the center that
would continue his care. This did not pose any problem for
pooled analyses, but it resulted in incorrect crediting of treat-
ment in feedback returns to individual centers. In 1978, a new
method for coping with this problem was introduced (Fig. 1) [7].
Within the treatment sequence, the letter code R (with a date)
indicates that the patient has been transferred from the center,
and the letter T (with a date) records that the patient has been
transferred into the center from another place. Sending and
receiving centers are identified by codes allocated to all centers
known to the Registry. Each center is sent a list of the center
codes for their country with the questionnaires.
Patient movements are thus recorded using unique codes as
part of the treatment sequence in the patient's Registry record
and each center only records the treatment given, with the
relevant dates, in that center. This approach provides for
accurate information in the "feedback" statistics provided by
the Registry to each center giving useful activity and perform-
ance figures. However, for scientific analyses carried out on a
demographic basis or on the pooled data, these "partial"
records are overlooked since they are individually incomplete.
A "compound" record which is the summation, in terms of
treatment sequence, is constructed in the center currently
treating the patient and, if the patient moves again, it will be
carried forward to the new center leaving a "partial" record
behind that terminates at the date of transfer.
The construction of a compound record, while not strictly
necessary, provides computational efficiency in scientific anal-
yses. In addition, the process of compounding the record
provides an excellent means of cross-checking and preserving
the quality of data held in the computer. Partial records which
have no associated compound records and vice versa for
centers reporting patients arriving from other units are very
rapidly identified and can be investigated since "to" and
"from" movement pointers are incorporated into the record of
transferred patients. At the same time, data consistency of fixed
characteristics such as sex, blood group, date of birth, primary
renal disease, and so forth can be readily checked for these
cases.
Four years' experience in handling patient transfers has
emphasized that this is the most difficult problem for the EDTA
Registry as it seeks to document an individual patient's history.
Inconsistencies in transfer reporting mean that at least 20% of
over 5,000 patient movements each year require manual eluci-
dation working with the actual questionnaires and interactively
on the computer file to link partial records and eliminate
duplicate records. Linking patient records across the interfaces
between Registries may help complete a patient's record when
partial records cannot be matched.
A further important reason for recording patient transfers is
to be able to merge the activity of single transplant centers,
even after patients have been transferred to other centers. The
Registry is impeded from making comparisons between various
groupings of centers by the practice of transferring patients.
The scale of the problem was immediately apparent when data
on patient transfers during 1978 were analyzed for 14 European
countries. Seventy-six percent of the transplants were per-
formed in the center in which the patient was dialyzed, but 23%
of the transplants were done on patients transferred to another
center in the same country (domestic transfers), and 1% in-
volved international transfers [7].
Standardization of transplantation follow-up results (ET). A
review of the extensive literature on the results of renal
transplantation reveals the need for a systematic approach in
this area. Generally, the actuarial life-table method is used. The
log-rank test is commonly used to assess the significance of
differences in two or more curves [81. Evaluation and compari-
son of results in the literature generate problems when (1) there
are no significance levels indicated at all, or (2) when they are
indicated only at selected time points.
Even when significance levels are properly indicated, presen-
tation of the subtotals of the log-rank analyses could provide
additional useful information.
Fig. 1. Computer handling of patient transfers(EDTA) showing how each center's data
make a partial record contributing to the
compound record. Codes: I, hospital HD; 2,
home HD; 3, IPD; 5, graft; 6, functioning
graft; 7, failed graft; R, transferred out; T,
transferred in.
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Consider the example set out in the top section of Table 1. It
shows the results of a log-rank analysis from a study designed to
examine whether or not there is a quantitative transfusion effect
on renal allograft survival. The differences between the four
groups of patients, and the trend are highly significant, suggest-
ing a strong quantitative transfusion effect. However, inspec-
tion of the ratios of observed and expected failures reveals that
the difference between each of the three transfused groups are
small compared to the differences between all of these groups
and the nontransfused group.
The results might, therefore, be more consistent with the
hypothesis that the effect is not quantitative but simply qualita-
tive. This hypothesis has been tested by excluding the nontrans-
fused group and repeating the analysis. The results (bottom
section of Table 1) reveal that the observed/expected ratios
(0/Es) are very similar, and there are no significant differences
between the results in the three groups.
The failure rates in the different groups may be compared by
using the ratio of their 0/E's [81. This calculation on the data in
the top section of Table 1 for the 0 and 1 transfusion groups
gives a ratio of 1.053/1.329 = 0.792. This suggests that a single
blood transfusion may prevent 1 — 0.792 or 20.8% of the
failures which would occur in nontransfused patients.
Methods for researching the patient file
Flexible software for analysis of the data base (UKTS).
Analytical software developed for national analyses by UKTS
has been written in such a way as to be as flexible as possible in
terms of the data subsets and character cohorts that can be
selected for analysis. The term flexible refers to the fact that
any patient characteristic identifiable or derivable from the data
can be used both to select patients for study and also to specify
how the data are to be used in a tabular or rate analysis. For
example, a particular study may wish to concentrate on female
patients between the ages of 25 to 30 years at the time of
grafting who had gout as a primary renal disease. The selection
process can be defined in this way and a similar approach used
to define the columns and rows of a table thus: The columns
could be defined waiting intervals for transplantation and the
rows could be patient blood group or some other characteristic.
It is both possible and practical to carry out "custom"
specified analyses on request to such an extent that a contribu-
tor to UKTS could, over a period of time, comprehensively
research the data base. It is essential to ensure the confidential-
ity of data relating to individual transplant units and to patients.
No contributor, analyzing the national data base, may carry out
any analyses leading to center or patient identifiable results
being obtained excepting the user's own unit. Thus, although
the total data base is available for research by individuals, it is,
to them, anonymous in its origins.
The type of analysis that could be performed has been limited
until recently to patient and graft survival studies with associat-
ed computer-generated graphics. However, it has now been
extended to cover a wide range of flexibly specified coincidence
tables and appropriate statistical support which can operate on
any data file held in the computer.
This particular philosophy has important implications for the
future. As more renal and transplant units acquire their own
microcomputers on which local data bases can be established,
maintained and researched, several possibilities become more
realistic. With a locally maintained computerized data base, it
becomes possible to plan for automated data exchange between
the local machines and the central registry computer. Such a
step will eliminate the various points at which transcription
errors can occur in pen-and-paper-to-machine methods of data
exchange. The quality of data held will improve as a direct
result thereby increasing the reliability, value, and precision of
national analyses.
Developments such as this involve the central registry in
supporting emulation for data transmission from a variety of
machines. It is a logical step to extend emulation from the very
simple requirements of data transmission to the more sophisti-
cated requirements of software resource sharing and remote job
activation. A direct result of such a step would be to make it
possible to obtain rapid investigation on the national data base
of important research findings arising out of a local
investigation.
One important area of long-term research which has arisen
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Failures
Transfusions Cases Observed Expected Obs/Exp
0 607 360 270.9
937 397 377.0Calculation A 2 to 5 2,154 879 919.0
>5 1,983 862 930.3
1.329
1.053
0.956
0.927
Overall significance: x2 = 37.09, P < 0.00001
Trend: x2 = 29.15, P < 0.00001
937 397 361.0
Calculation B 2 to 5 2,154 897 881.5
>5 1,983 862 894.8
1.100
0.997
0.963
Overall significance: x2 = 4.80, P = 0.091
Trend: x2 = 4.03, P = 0.045
a Calculation A includes all groups; in calculation B the nontrans-
fused group has been excluded.
out of the centralized analyses of the UKTS, and which serves
as an excellent example of one which can expect to benefit from
the kind of developments described above, is that of the so-
called "center effect" in kidney allograft survival analyses [91.
From the curves shown in 1976, and in subsequent years, the
wide range of values arising in individual transplant units was
evident. A number of subsequent studies reflect the continuing
level of interest in this phenomenon [10, 11]. Figure 2 shows
two graphs appearing in the UKTS Annual Reports of 1976 and
1981 and demonstrates a marked change in the spread of
survival values. Although the average survival of the total
data has moved upwards by a small amount, the extreme values
giving rise to the spread have changed markedly over the
same period. It might be conjectured that the interest in
the phenomenon has resulted in a noticeable change in its
magnitude.
The components of the center effect are undoubtedly many
and complex in their interactions and provide much valuable
material for comparison and research. The possibility of rapid,
automated access to the national data base and to the compo-
nent data files in the individual centers will make it possible to
evaluate the components of this phenomenon as an "on-going"
and even interactive activity for centers with capable micro-
computers or by accessing the facilities of the central computer
from a remote machine.
The problem of heterogeneity (ST). Since the individual
transplantation center performs a relatively small number of
kidney transplantations per year, it is very often necessary to
pool data from several centers to assess the importance of a
particular treatment within a reasonably short period. Howev-
er, this entails a considerable risk of introducing bias due to the
heterogeneous nature of the data. Thus, for example, if a given
center does not believe in the blessings of HLA matching and
for some other reason also has a rather bad graft outcome the
uncritical inclusion of these data in the study may give a false
association of bad matching with a low graft survival. The
danger of such bias is most likely when pooling data from
several centers, but it may also occur in pooling data from
different prognostic strata of some other important factor for
graft survival, if graft outcome and matching policy is for some
reason or another associated.
The Scandiatransplant follow-up file is maintained through a
collaboration between Scandiatransplant and the EDTA Regis-
try, which has supplied the post-transplantation information up
to 1980. The file contained 4,519 patient reports of which 86%
had valid follow-up information, the deficit being due to either
negligence or inaccuracy in the clinical departments' yearly
report to EDTA. For the present purpose the material was
divided into four groups with zero, one, two and three, or four
mismatching HLA-A, -B antigens, respectively.
In the analysis presented here, we have applied retrograde
stratification in combination with the log-rank test to see
whether the beneficial effect of HLA-A, -B matching demon-
strated in the Scandinavian data [12] could, in fact, be due to
bias.
The statistical methods have been thoroughly described by
Peto et al [81. An essential aspect is the possibility of comparing
the entire course of the actuarial survival curves and not only a
particular section. Furthermore, in the final test it incorporates
statistical information on whether the groups are ordered in a
natural way (that is, trend), and not merely whether there is
significant heterogeneity between the various groups. In the
Table 1. Effect of pretreatment blood transfusions on first cadaver
renal allograft survival in Eurotransplant dataa
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Fig. 2. Cumulative first cadaver graft survival in individual United
Kingdom centers. The upper panel—represents 1976, lower panel,
1981. The lines are interrupted where less than ten grafts are "at risk."
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Table 2. Retrograde stratification and log-rank test to evaluate benefit of HLA-A and -B matching in Scandiatranspiant data, December 31, 1979
All
x2 trend
26
P — 3 x l0 Centera22 Yeara26 Agea25 Ab screenb25 ABOC25 Sex'26
Significant P < 0.05 GO05
ST
1974
1977
45 to 54
25 to 34
35to44
Positive
Negative
0 —* 0
non 0 — non 0
?
9 —*
P < 0.10 HE 1975 15 to 24 d —*d—*
d
9
Not significant LU
CPH
AR
UP
1976
1973
1978
1979
<15
>55
0 — non 0 9 — 9
a The recipient's center affiliation, year, and age at transplantation strata are ranked according to the decreasing PT value.
b The presence or absence of lympho-cytotoxic antibodies was prior to transplantation.
The ABO blood group of donor and recipient: Donor ABO — Recipient ABO.
d Sex of donor and recipient: Donor sex — Recipient sex, ? denotes that the sex combination is unknown. (For an explanation, see the text.)
Scandiatranspiant analysis the cumulative 2-year survival rates
were as follows: 0 HLA-A,-B incompatibility, 53.2%; 1 HLA-
A,-B incompatibility, 50.5%; 2 HLA-A,-B incompatibilities,
42.1%; 3 or 4 HLA-A,-B incompatibilities, 32.3%. These data
are based on 2,597 transplantations carried out in 1973 to 1979,
a period with uniform HLA-typing. Thus, it appears that there
is a natural ordering; the survival rate decreases in a systematic
way with an increasing number of incompatible antigens, and,
when the data are analyzed for the existence of trend a x2 of26
corresponding to P < 10 is obtained (Table 2). This proves
beyond doubt that the differences in survival rate cannot be a
chance phenomenon.
In the second part of the analysis, the data were initially
divided into different groups or strata which had been shown to
be clinically relevant. The factors studied comprise center, age
of patient, year of grafting, presensitization of the recipient,
ABO blood groups, and recipient-donor sex combinations. The
main results are set out in Table 2.
To examine center effect, for example, the patients were
primarily grouped according to the eight transplantation centers
(GO, OS, ST, and so forth). Secondly, within each center the
patients were grouped into the four histocompatibility grades
and the x2 for trend calculated. This gives significant P values
for the effect of HLA matching (at the 0.05 level) for three
centers (that is, GO, OS, and ST), a P value < 0.10 for HE
while the remaining four centers (LU, CPH, AR, and UP) had
values that were not significant although the survival curves
were ordered in the expected way in all four centers. In the
third step these results were then combined in a way described
by Peto et a! [8] so that the resultant x2 is unbiased by chance
correlation between matching and the performance of the
particular center. The x2 obtained in this particular case was 22
(see Table 2, top of column 3). According to Peto eta! [8], "This
(Chi-square) is unbiased whether or not there is marked hetero-
geneity in the types of patients admitted or in the general
standards of medical management at different centers." The x2
is very close to the overall x2 of 26 and is still enormously
significant. The corresponding result for the other factors
investigated appears also from Table 2, and it can be seen that
the overall x2 values are in all instances persuasively significant.
The reason for choosing the six particular factors was that our
data show a highly significant cumulative graft survival when
the centers are compared before partitioning into histocompati-
bility groups, and this is also the case for year and age while the
difference is insignificant in the groups Ab screen, ABO, and
sex.
Thus, our analysis shows that the HLA effect found in the
pooled data is real and not an artifact due to association, by
chance or bias of HLA matching, to some particular prognostic
factors.
The table also shows that the HLA effect only reaches
significance in some strata of each factor. This is, however, not
more than one would expect when the relatively small numbers
were divided into even smaller groups, and it is noteworthy that
every group studied showed the expected ordering of the HLA
groups.
Unfortunately, the Scandiatransplant file does not yet con-
tain a sufficient number of DR-typed cases to warrant a special
analysis, but due to the strong linkage disequilibrium in the
HLA system, matching the HLA-B antigens is an indirect way
of matching for DR. Thu, the present analysis lends credibility
to the strong effect of the HLA system as a whole in cadaver
kidney transplantation and this might well be primarily depen-
dent on the DR matching.
New trends in analyses (ET). Inspection of follow-up results
reveals certain paradoxes. Some badly mismatched grafts are
still functioning many years after transplantation while others,
which were well matched, were lost relatively rapidly. These
facts suggest that unknown factors or interactions between
multiple factors may play a significant role in determining
allograft survival. One such factor could be the recipient's
immune responsiveness and evaluation of this on a multicenter
basis could prove useful in the selection of donor-recipient
pairs.
It has been suggested that the identification of new factors or
interactions could be helped by modifying follow-up files so that
they are not limited to a statement of graft failure or function
but also include data on the timing, severity, and treatment of
rejection episodes. The collection of such data from different
centers would depend on the standardization of follow-up
intervals and laboratory investigations.
A consideration of the above factors led to a conference
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sponsored by the Committee on Medical and Public Health
Research of the Commission of European Communities be-
tween representatives of major European organ exchange orga-
nizations in France, the Netherlands, Italy, Scandinavia, and
the United Kingdom [13]. Different techniques for the perform-
ance of multivariate analyses were discussed and lines of
communication were established between the centers which
were engaged in such studies. It is hoped that these new
analytical techniques, applied to the expanded, more informa-
tive data bases of the European Registries will provide a better
insight into the factors which are responsible for allograft
rejection.
Methods for improving the service to centers
Verifying the reliability of donor typings (ET). HLA-A, -B,
and DR matching form the core of donor-recipient selection
programs. Consequently, an objective evaluation of the reliabil-
ity of donor HLA typings could provide a useful service to
transplantation centers.
At the 1980 meeting of Eurotransplant Tissue Typing Com-
mittee, Van Rood suggested that testing the donor typing
results for Hardy-Weinberg equilibrium could serve that pur-
pose since the donor population, the majority being accident
victims, constitutes a random sample of the population from
which it is drawn, Deviations in the results of those analyses
from the Hardy-Weinberg expectations would indicate an error
in antigen definition. In most cases, the faulty antigen is clearly
identified since it appears in most or all of the combinations
with significant contributions to the x2.
The performance of this relatively simple analysis by Nation-
al Reference Centers on the submitted donor typings provides
them with a useful index of a particular typing center's perform-
ance. The feedback of the results to the centers should permit
them to monitor and improve their typings.
Pool size requirements and HLA matching (ST). Many
factors are involved in the determination of the optimal extent
of collaborators among kidney transplant centers. For, while it
is evident that matching improves with increasing pooi size, the
burden in administration, communication, and transportation
sets an upper practical limit for kidney exchange. It is, there-
fore, important to know the relationships between the pool size
and the expected percentage of random donors for which a
matched recipient will be found.
In Figure 3, this relationship has been derived theoretically
on the basis of the HLA-A, -B haplotype frequency in the
Danish population (which is representative of the major Euro-
pean exchange organizations) accounting for linkage disequilib-
rium and considering eight HLA-A and 17 HLA-B antigens [14,
151. Three sets of curves are shown corresponding to four-
antigen identity, identity for four or less antigens and compati-
bility, that is, the donor has no antigens foreign to the recipient.
The two curves in each set represent, respectively, the situa-
tions in which only one kidney is available per donor and in
which both kidneys are available. These curves also take into
account matching for the ABO blood group system.
It is not possible here to give the formulae and their deriva-
tions for all six curves. We will, therefore, give the formula for
calculation of the probability P'  I (N) of finding at least one
ABO and HLA compatible recipient to a random donor for a
pool of N individuals. This corresponds to compatibility in the
single graft situation:
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Fig. 3. Prediction of relationships between pool size and percentage of
HLA-A and -B compatible and identical matches, based on haplotype
frequency in Danish population. Symbols are: compatibility (- - -
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Fig. 4. Prediction of relationships between pooi size and percentage of
HLA-DR matches.
 1(N) = p qj [1 — (1 —
Id
where I denotes the set of ABO phenotypes; I = {A, B, 0, AB};
m is the number of HLA-A,B phenotypes (that is, 5,698 in this
case); p1 is the frequency of the ith ABO group; qj is the
frequency of the jth HLA-type; and i1 = d1q j, in which
I ifi=0
I PA +PAeifi=Ad1= < PB +PABifi=B
1PAB ifi—AB
and q j is the combined frequencies of recipient with the HLA
phenotypes which render the jth donor's phenotype
compatible.
The major differences between the three curves are in the
interval 0 to 2,000 where the curves attain "saturation level"
and become nearly parallel with 10% increases from 2,000 to
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Fig. 5. EDTA Registry feedback to hypothetical individual center, part I (see text for description).
4,000 as well as 4,000 to 9,000. It should be noted that the
maximum attainable is 100% for compatibility as well as identi-
ty while it is only 70% for full-house identity since only 70% of
random individuals have four antigens. The validity of these
calculations was established by a model study in which the 170
grafts from 97 donors, which became available during January,
1977, in the participating centers, were manually matched with
the list from France Transplant (N = 1,500), Eurotransplant(1,000), and Scandiatransplant (500). The results from this
exercise very much agreed with the theoretically derived
figures.
It appears from Figure 3 that, if the aim is to obtain HLA-A,
-B compatibility most of the advantages of collaboration are
attained when the waiting list includes about 1,000 patients,
while it must include as many as 2,000 individuals if full-house
identity is required. Thus, depending on the level of HLA
matching which is sought, the optimal pooi size must be
between 1,000 and 2,000 patients.
The corresponding curves for the DR system considering
eight DR antigens with gene frequencies as found in the Danish
population [161 are shown in Figure 4. Again the maximum for
full-house identity is determined by the proportion of individ-
uals with two antigens. It appears that most of the advantage of
pooling is attained with poois of a few hundred patients.
Thus, if the finding reported from some centers [171 that the
benefit of HLA-A, -B matching in addition to DR matching is
negligible is confirmed in larger series, life will certainly be-
come much easier for the transplantation organizations. There
will, however, still be the 20 to 30% of patients with HLA-A, -B
antibodies who will require HLA-A, -B matching to secure a
negative T cell crossmatch, although there are indications that
this strict requirement may be relaxed [181.
The shape of the curves has not been determined for the case
when simultaneous HLA-A, -B, and DR matching is required.
They will certainly be much flatter than for HLA-A, -B full-
house identity. In practice such a degree of perfection will be
impossible to secure.
Center feedback (EDTA). The EDTA Registry prepares a
feedback of each center's reported activity in dialysis and
transplantation. The purpose of this feedback is, first, to give an
additional service to contributors in return for their work in
completing the Registry questionnaires, and second, to provide
an opportunity for checking that data returns are complete and
accurate.
The feedback is prepared in two parts. Part 1 is a computer
written breakdown of each center's activities divided into six
sections (Fig. 5). The first section reports patient numbers
according to sex and mode of treatment. The second section
shows patient data for the year of the Report. This is the flow of
patients into different modes of treatment, including new pa-
tients, transferred patients, and deaths. The third section shows
the number of patients in each of eight different age groups. The
fourth section contains a complicated calculation of the number
of hemodialyses computed from the average number of dialyses
per week reported for each patient and the sum of weeks each
patient spent on hemodialysis during the year. The fifth section
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Fig. 6. EDTA Registry feedback to hypothetical individual center, part 2 (see text for description).
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tables the frequencies of the ABO blood groups in various
subsets of patients. The sixth section gives the distribution of
patients under main groups of dialysers.
Part 2 is a graphical presentation of each center's achieve-
ments in eight panels of histograms, pie charts, and actuarial
curves (Fig. 6), which is prepared using color graphics (not
reproduced in the figure). Panel 1 is a histogram showing the
age distribution of patients on December 31st in the year of the
report. A red histogram distinguishes dialysis patients and a
black histogram, transplanted patients. Panel 2 indicates the
way the center's patient load is growing. A blue line shows the
total "stock" of patients on all modes of therapy, divided into
those on hemodialysis and those alive with a functioning graft.
The lowest line shows the "flow" of all new patients for the
year. Panel 3 is a pie chart demonstrating the proportions of
patients with main primary renal diseases. Panels 4 and 5 are pie
charts demonstrating main causes of death in dialysis patients
(panel 4) and patients dying with a functioning transplant (panel
5). Panels 6 and 7 are cumulative patient survival curves
achieved in the center by all treatments combined. Panel 6
shows a series of curves according to age at the beginning of
treatment. Panel 7 denotes survivals according to year of
commencement of therapy. Panel 8 represents the survival of
renal grafts carried out during the year of report in the center.
Separate curves are shown for cadaver grafts and for living
donor grafts. If the center did not report transplantation, then
survival according to the current mode of dialysis is given.
Conclusions
Computers have made possible the development of Registries
containing large amounts of data from large numbers of end-
stage renal failure patients. The development of smaller com-
puters placed in dialysis and transplant centers creates the
opportunity for improved collaboration between centers and in
the central Registries.
Central Registries have a great opportunity to research
multiple variables and to analyze groups of patients according
to age, primary renal disease, and many other factors. All these
studies may be of direct relevance to clinical decisions. The
maintenance of an accurate patient file is the essence of a
reliable data base. The more that this can be refined and
indexed the more confidence we can have in the reliability of
the data base. Two-way interchange between contributing
centers and the central Registries is an important activity to
promote reliable data and provides an important service to the
centers. The future for central Registries offers fascinating
research potential and fruitful collaboration.
Summary
The histories and present roles of four European Registries
are described. Three are transplant sharing organizations, Eur-
otranspiant (ET), Scandiatransplant (ST), and the United King-
dom Transplant Service (UKTS). The Registry of the European
Dialysis and Transplant Association is a patient Registry that
tracks patients on dialysis as well as after transplantation and
follows them from center to center. The transplant organiza-
tions collaborate by linking patient records on the EDTA
Register.
These large central Registries have evolved specialized com-
puter methodologies for recording the follow-up of patients,
researching the patient file, and improving the service to
centers. The log-rank test is useful for the evaluation of pooled
results. Reliability of donor typings can be verified by testing
results for the Hardy-Weinberg equilibrium. A method for the
prediction of pool size required to find matched recipients is
described. Collaborative studies have been carried out in an
attempt to discover the factor(s) responsible for the "center
effect." New trends in analysis of transplant results will include
detailed documentation of rejection episodes. Compliance by
centers contributing to the transplant organizations is ensured
by the need for organ interchange, whereas the EDTA Registry
depends on the directors of centers being motivated by the
publication of pooled statistics and results and by the provision
of feedback information to the individual units.
Reprint requests to Dr. A. J. Wing, European Dialysis and Trans-
plant Registry, St. Thomas' Hospital, London SEJ 7EH, United
Kingdom
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